BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1700941)

  • 1. CD5+B cells in rheumatoid arthritis and Sjögren's syndrome.
    Maini RN; Plater-Zyberk C; Brown CM; Aghamohammadi S; Brennan FM; Feldmann M
    Clin Exp Rheumatol; 1990; 8 Suppl 5():67-8. PubMed ID: 1700941
    [No Abstract]   [Full Text] [Related]  

  • 2. CD5 positivity on peripheral blood B lymphocytes in patients with primary Sjögren's syndrome.
    Zeher M; Surányi P; Szegedi G
    Allergol Immunopathol (Madr); 1990; 18(2):75-8. PubMed ID: 1695475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coordinate expansion of 'fetal type' lymphocytes (TCR gamma delta+T and CD5+B) in rheumatoid arthritis and primary Sjögren's syndrome.
    Brennan F; Plater-Zyberk C; Maini RN; Feldmann M
    Clin Exp Immunol; 1989 Aug; 77(2):175-8. PubMed ID: 2476268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunologic and viral factors in Sjögren's syndrome.
    Talal N
    Clin Exp Rheumatol; 1990; 8 Suppl 5():23-6. PubMed ID: 1700940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sjögren's syndrome: an oligo-monoclonal B cell process.
    Tzioufas AG; Katsikis PD; Youinou PY; Moutsopoulos HM
    Clin Exp Rheumatol; 1990; 8 Suppl 5():17-21. PubMed ID: 1700939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 'Fetal-type' B and T lymphocytes in rheumatoid arthritis and primary Sjögren's syndrome.
    Plater-Zyberk C; Brennan FM; Feldmann M; Maini RN
    J Autoimmun; 1989 Jun; 2 Suppl():233-41. PubMed ID: 2476142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B cells expressing CD5 in minor labial salivary glands of patients with primary Sjögren's syndrome.
    Zeher M; Surányi P; Nagy G; Szegedi G
    Arthritis Rheum; 1990 Mar; 33(3):453. PubMed ID: 1690544
    [No Abstract]   [Full Text] [Related]  

  • 8. Expression of CD5 and CD23 on B cells of patients with rheumatoid arthritis, systemic lupus erythematosus and Sjögren's syndrome. Relationship with disease activity and treatment.
    Ebo D; DeClerck LS; Bridts CH; Stevens WJ
    In Vivo; 1994; 8(4):577-80. PubMed ID: 7534494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD5 B cells in autoimmunity.
    Talal N; Dauphinee M; Ahmed SA
    Ann N Y Acad Sci; 1992 May; 651():551-6. PubMed ID: 1376075
    [No Abstract]   [Full Text] [Related]  

  • 10. Expression of CD5 and CD72 on T and B cell subsets in rheumatoid arthritis and Sjögren's syndrome.
    Jamin C; Lamour A; Pennec YL; Hirn M; Le Goff P; Youinou P
    Clin Exp Immunol; 1993 May; 92(2):245-50. PubMed ID: 7683586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levels of CD5+ B cells are not increased in probands or relatives in a family study of primary Sjögren's syndrome.
    Foster HE; Calvert JE; Kelly CA; Griffiths ID
    Autoimmunity; 1992; 12(3):207-14. PubMed ID: 1285317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD5+ B cells in nonorgan-specific autoimmune diseases: a fresh look.
    Youinou P; Lydyard PM
    Lupus; 2001; 10(8):523-5. PubMed ID: 11530992
    [No Abstract]   [Full Text] [Related]  

  • 13. Aberrant expression of CD6 on B-cell subsets from patients with Sjögren's syndrome.
    Alonso R; Buors C; Le Dantec C; Hillion S; Pers JO; Saraux A; Montero E; Marianowski R; Loisel S; Devauchelle V; Youinou P; Renaudineau Y
    J Autoimmun; 2010 Dec; 35(4):336-41. PubMed ID: 20810246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral blood CD5+ B cell subset in the remission phase of systemic connective tissue diseases.
    Markeljević J; Batinić D; Uzarević B; Bozikov J; Cikes N; Babić-Naglić D; Horvat Z; Marusić M
    J Rheumatol; 1994 Dec; 21(12):2225-30. PubMed ID: 7535356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Detection of serum anti-salivary duct antibody and its clinical significance].
    Zhang H; Shi GY; Cai XH
    Zhonghua Nei Ke Za Zhi; 1990 Nov; 29(11):666-8, 702. PubMed ID: 2086008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal antibody defined T cell subsets in primary and secondary Sjögren's syndrome.
    Fossaluzza V; Rossi P; Tosato F; Pirrone S; Tonutti E; Sala PG
    Boll Ist Sieroter Milan; 1986; 65(5):440-2. PubMed ID: 3493793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expanded clinical and basic profile of rheumatoid factors. 6. Rheumatoid factors in patients with Sjögren's syndrome].
    Ezaki I; Wada T; Nonaka S; Kamimiya M; Nobenaga T
    Ryumachi; 1988 Dec; 28(6):425-8. PubMed ID: 3249981
    [No Abstract]   [Full Text] [Related]  

  • 18. Rheumatoid arthritis complicated by infection with the human immunodeficiency virus and the development of Sjögren's syndrome.
    Calabrese LH; Wilke WS; Perkins AD; Tubbs RR
    Arthritis Rheum; 1989 Nov; 32(11):1453-7. PubMed ID: 2573359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cell receptor expression in Sjögren's syndrome.
    Zumla A; Mathur M; Stewart J; Wilkinson L; Isenberg D
    Ann Rheum Dis; 1991 Oct; 50(10):691-3. PubMed ID: 1720300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue-type in the thymus of a patient with Sjögren's syndrome and rheumatoid arthritis.
    Kim JM
    J Korean Med Sci; 2003 Dec; 18(6):897-900. PubMed ID: 14676452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.